- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: her2 positive locally advanced breast cancer
Total 103272 results
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedER+ / HER2- Advanced Breast CancerChina
-
Zai Lab (Shanghai) Co., Ltd.CompletedHER2 Positive Metastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Metastatic Breast CancerChina
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Cancer Hospital; First Affiliated Hospital of Zhejiang University; Sir... and other collaboratorsUnknownColorectal CancerChina
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | PSA Progression | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States
-
Hospital do CoracaoPfizerRecruitingMetastatic Breast Cancer | Breast Cancer Stage IVBrazil
-
Institut für Klinische Krebsforschung IKF GmbH...Medizinische Hochschule Hannover, Germany, Prof. Dr. Arndt Vogel; MSD Sharp...Not yet recruitingBiliary Tract Cancer | HER2 Gene Mutation
-
Dana-Farber Cancer InstituteGenentech, Inc.Recruiting
-
University of MiamiGenentech, Inc.TerminatedBreast Cancer | Metastatic Breast CancerUnited States
-
Fudan UniversityRecruiting
-
The Netherlands Cancer InstituteSeagen Inc.Recruiting
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer (MBC) | Locally Advance Breast Cancer (LABC)United Kingdom, Spain
-
Shanghai Fosun Pharmaceutical Industrial Development...Recruiting
-
Palleos Healthcare GmbHPfizer; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUP; AGO-TraFo; AGO-B; Deutsche...Terminated
-
DualityBio Inc.BioNTech SERecruiting
-
Medstar Health Research InstituteGenentech, Inc.TerminatedHER-2 Positive Metastatic Breast CancerUnited States
-
Swiss Group for Clinical Cancer ResearchCompletedMetastatic Breast CancerFrance, Switzerland, Netherlands, Germany
-
Jenny C. Chang, MDThe Methodist Hospital Research InstituteCompletedMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsTerminatedAdvanced Gastric CancerSpain, Belgium, France, Italy, United States, Korea, Republic of, Japan, Germany
-
SCRI Development Innovations, LLCSanofi; GlaxoSmithKline; NovartisTerminatedMetastatic Breast Cancer With Intracranial MetastasesUnited States
-
RemeGen Co., Ltd.CompletedUrothelial CarcinomaChina
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.Not yet recruitingER Positive/HER2 Low Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHR Positive/HER2 Low Expression Metastatic Breast CancerChina
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerGermany
-
Fudan UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
University of Alabama at BirminghamTesaro, Inc.; Susan G. Komen Breast Cancer Foundation; Translational Breast Cancer... and other collaboratorsRecruitingMetastatic Breast Cancer | HER2 Positive Breast CarcinomaUnited States
-
ETOP IBCSG Partners FoundationPfizer; Hoffmann-La RocheCompletedBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorFrance, Switzerland, Belgium, Italy
-
Korean Cancer Study GroupUnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Janssen Research & Development, LLCCompletedPostmenopausal | Metastatic ER+ Her2- Breast CancerUnited States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
-
Organisation for Oncology and Translational ResearchUnknownLetrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal WomenER Positive, HER2 Negative Breast CancerChina
-
Translational Oncology Research InternationalGenentech, Inc.Completed
-
Peking University Cancer Hospital & InstituteRecruiting
-
Pierre Fabre MedicamentIqvia Pty LtdRecruitingBreast Cancer | HER2-positive Breast Cancer | Adjuvant TherapyBelgium
-
Tianjin Medical University Cancer Institute and...Not yet recruitingAdvanced HR+ HER2 Negative Breast Carcinoma
-
Tianjin Medical University Cancer Institute and...RecruitingAdvanced HR+ HER2 Negative Breast CarcinomaChina
-
Institut fuer FrauengesundheitSamsung Bioepis Co., Ltd.RecruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer FemaleGermany
-
Saint Luke's Health SystemNovartis PharmaceuticalsRecruitingMetastatic Breast Cancer | HER2-negative Breast CancerUnited States
-
First Affiliated Hospital of Zhejiang UniversityRecruitingBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorChina
-
Royal Marsden NHS Foundation TrustPfizer; AstraZeneca; Institute of Cancer Research, United Kingdom; UNICANCER; Gustave... and other collaboratorsRecruitingHER2-negative Breast Cancer | ER+ Breast CancerUnited Kingdom, France
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Shandong Cancer Hospital and InstituteUnknownMetastatic Breast Cancer | HER2-positive Breast Cancer
-
Ahon Pharmaceutical Co., Ltd.Zhejiang Cancer Hospital; Fudan University; Sir Run Run Shaw HospitalUnknown
-
Baptist Health South FloridaSeagen Inc.RecruitingHER2-positive Breast Cancer | Brain MetastasesUnited States
-
GlaxoSmithKlineCompleted
-
University of Alabama at BirminghamRecruiting
-
Fondazione Sandro PitiglianiGenomic Health®, Inc.; Istituto Toscano TumoriActive, not recruiting
-
Yongchang ZhangRecruitingHER2 Insertion Mutation Positive Advanced NSCLCChina
-
Kangbuk Samsung HospitalRecruitingHER2-positive Advanced Gastric CancerKorea, Republic of
-
Cancer Institute and Hospital, Chinese Academy...UnknownBreast Cancer | Brain MetastasesChina
-
NSABP Foundation IncPfizerCompleted